236 related articles for article (PubMed ID: 6722784)
1. Proliferation-linked increase in phosphoribosylformylglycinamidine synthetase activity (EC 6.3.5.3).
Elliott WL; Weber G
Cancer Res; 1984 Jun; 44(6):2430-4. PubMed ID: 6722784
[TBL] [Abstract][Full Text] [Related]
2. Increased 5-phospho-alpha-D-ribose-1-diphosphate synthetase (ribosephosphate pyrophosphokinase, EC 2.7.6.1) activity in rat hepatomas.
Baló-Banga JM; Weber G
Cancer Res; 1984 Nov; 44(11):5004-9. PubMed ID: 6091867
[TBL] [Abstract][Full Text] [Related]
3. 1-Phosphatidylinositol 4-kinase: an enzyme linked with proliferation and malignancy.
Rizzo MT; Weber G
Cancer Res; 1994 May; 54(10):2611-4. PubMed ID: 8168087
[TBL] [Abstract][Full Text] [Related]
4. Behavior of transaldolase (EC 2.2.1.2) and transketolase (EC 2.2.1.1) Activities in normal, neoplastic, differentiating, and regenerating liver.
Heinrich PC; Morris HP; Weber G
Cancer Res; 1976 Sep; 36(9 pt.1):3189-97. PubMed ID: 10080
[TBL] [Abstract][Full Text] [Related]
5. Enzymic capacities of purine de Novo and salvage pathways for nucleotide synthesis in normal and neoplastic tissues.
Natsumeda Y; Prajda N; Donohue JP; Glover JL; Weber G
Cancer Res; 1984 Jun; 44(6):2475-9. PubMed ID: 6327016
[TBL] [Abstract][Full Text] [Related]
6. Increased uridine kinase (ATP: uridine 5'-phosphotransferase; EC 2.7.1.48) activity in human and rat tumors.
Shen F; Look KY; Yeh YA; Weber G
Cancer Biochem Biophys; 1998 Jun; 16(1-2):1-15. PubMed ID: 9923963
[TBL] [Abstract][Full Text] [Related]
7. Imbalance of purine metabolism in hepatomas of different growth rates as expressed in behavior of xanthine oxidase (EC 1.2.3.2).
Prajda N; Morris HP; Weber G
Cancer Res; 1976 Dec; 36(12):4639-46. PubMed ID: 187329
[TBL] [Abstract][Full Text] [Related]
8. 1-Phosphatidylinositol 4-phosphate 5-kinase (EC 2.7.1.68): a proliferation- and malignancy-linked signal transduction enzyme.
Singhal RL; Prajda N; Yeh YA; Weber G
Cancer Res; 1994 Nov; 54(21):5574-8. PubMed ID: 7923199
[TBL] [Abstract][Full Text] [Related]
9. Phospholipase C (EC 3.1.4.11): a malignancy linked signal transduction enzyme.
Yang H; Shen F; Herenyiova M; Weber G
Anticancer Res; 1998; 18(3A):1399-404. PubMed ID: 9673347
[TBL] [Abstract][Full Text] [Related]
10. Increased carbamoyl-phosphate synthetase II concentration in rat hepatomas: immunological evidence.
Reardon MA; Weber G
Cancer Res; 1985 Sep; 45(9):4412-5. PubMed ID: 4028025
[TBL] [Abstract][Full Text] [Related]
11. Increased thymidylate synthase (EC 2.1.1.45) activity in normal and neoplastic proliferation.
Hashimoto Y; Shiotani T; Eble JN; Glover JL; Weber G
Cancer Biochem Biophys; 1988 Jul; 10(1):1-10. PubMed ID: 3224329
[TBL] [Abstract][Full Text] [Related]
12. Negative correlation of L-glutamine concentration with proliferation rate in rat hepatomas.
Sebolt JS; Weber G
Life Sci; 1984 Jan; 34(3):301-6. PubMed ID: 6141511
[TBL] [Abstract][Full Text] [Related]
13. Guanosine-5'-phosphate synthetase and guanosine-5'-phosphate kinase in rat hepatomas and kidney tumors.
Boritzki TJ; Jackson RC; Morris HP; Weber G
Biochim Biophys Acta; 1981 Mar; 658(1):102-10. PubMed ID: 6260205
[TBL] [Abstract][Full Text] [Related]
14. In vivo inactivation of formylglycinamidine ribonucleotide synthetase in rat hepatoma.
Elliott WL; Weber G
Biochem Pharmacol; 1985 Jan; 34(2):243-8. PubMed ID: 3966925
[TBL] [Abstract][Full Text] [Related]
15. Glycosyltransferases and glycosidases in Morris hepatomas.
Bauer CH; Vischer P; Grünholz H; Reutter W
Cancer Res; 1977 May; 37(5):1513-8. PubMed ID: 192453
[TBL] [Abstract][Full Text] [Related]
16. Imbalance of purine metabolism in hepatomas of different growth rates as expressed in behavior of glutamine-phosphoribosylpyrophosphate amidotransferase (amidophosphoribosyltransferase, EC 2.4.2.14).
Prajda N; Katunuma N; Morris HP; Weber G
Cancer Res; 1975 Nov; 35(11 Pt 1):3061-8. PubMed ID: 241484
[TBL] [Abstract][Full Text] [Related]
17. Regulatory properties and behavior of activity of carbamoyl phosphate synthetase II (glutamine-hydrolyzing) in normal and proliferating tissues.
Aoki T; Morris HP; Weber G
J Biol Chem; 1982 Jan; 257(1):432-8. PubMed ID: 7053379
[TBL] [Abstract][Full Text] [Related]
18. Neoplastic transformation-linked alterations in arginyl-tRNA synthetase activity.
McCune SA; Morris HP; Weber G
Biochim Biophys Acta; 1979 Feb; 561(2):410-20. PubMed ID: 427164
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of neprilysin (neutral endopeptidase 24.11) in rat and human hepatocellular carcinomas.
Dragović T; Deddish PA; Tan F; Weber G; Erdös EG
Lab Invest; 1994 Jan; 70(1):107-13. PubMed ID: 8302012
[TBL] [Abstract][Full Text] [Related]
20. Substrate specificity of formylglycinamidine synthetase.
Schendel FJ; Stubbe J
Biochemistry; 1986 Apr; 25(8):2256-64. PubMed ID: 2939878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
